It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn
At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.
Latest News
Medicines Discovery Catapult celebrate British Science Week by bringing junior and senior scientists together
To celebrate British Science Week, Medicines Discovery Catapult have brought their most experienced scientists together with their newest scientists to talk about their motivations to
Medicines Discovery Catapult welcomes UK Government’s long-term investment in life sciences innovation
In response to the UK Government’s Budget 2020 , Chris Molloy, CEO of the Medicines Discovery Catapult said: “Today’s budget announced £200M in funding directly targeted at the
Medicines Discovery Catapult Nurture Next Generation Drug Discovery Researchers
Medicines Discovery Catapult (MDC) have welcomed a cohort of MRC-funded PhD students as part of a training, talent and skills agenda to help develop the